Stem Cell-Based Therapies for Type 2 Diabetes: Exploring New Frontiers in Treatment
Type 2 Diabetes (T2D) has emerged as a global health challenge, affecting millions worldwide. It is a chronic condition characterized by insulin resistance and the inability to regulate blood sugar levels effectively. While conventional treatments like medication and lifestyle changes are helpful, they often fall short in addressing the root cause of the disease. This […]
Revolutionary Type 1 Diabetes Cure: Melton’s Abarca Prize Triumph
Professor Douglas A. Melton has made a groundbreaking contribution to the medical field with his research focused on curing Type 1 diabetes. His innovative approach involves transplanting insulin-producing cells, particularly pancreatic beta cells. These cells are capable of measuring glucose levels and secreting the appropriate amount of insulin, which has led to a “functional cure” […]
Revolutionary Stem Cell Cure for Type 1 Diabetes?
The video below titled “Beta Cells From Stem Cells Nearing a Cure for Type 1 Diabetes” features Dr. Anne L. Peters discussing the results of clinical trials involving beta cells derived from stem cells in patients with type 1 diabetes. The trials were conducted by a company named Vertex, for which Dr. Peters serves on […]
Insulin Independence: Is This the Future for Type 1 Diabetes Patients?
The press release from the American Diabetes Association presents promising findings from an ongoing clinical trial of VX-880, a novel stem cell-derived islet cell therapy for individuals with type 1 diabetes (T1D). The study, presented at the 83rd Scientific Sessions of the American Diabetes Association, demonstrates the potential of this therapy as a future treatment […]
Stem Cells: The Secret Weapon in the War Against Diabetes?
If you’re reading this, chances are you or someone you love is grappling with diabetes. It’s a tough journey, isn’t it? The constant monitoring of blood sugar levels, the dietary restrictions, the insulin injections – it can all feel overwhelming. But what if I told you there’s a glimmer of hope on the horizon? What […]
How Stem Cells Are Transforming Autoimmune Care
In a recent video by Dream Body Clinic, Josh, the host, discussed the potential of stem cell therapy in treating autoimmune diseases. The video is part of a series called the Ultimate Guide to Stem Cell Therapy. Josh covers several autoimmune diseases, including multiple sclerosis, lupus, Hashimoto’s disease, Crohn’s disease, fibromyalgia, ulcerative colitis, and type […]
From Stem Cells to Insulin Producing ß-cells
In this round table video clip, Dr. Camillo Ricordi and Dr. Melena Bellin discuss the current strategies being studied for restoring glycemic control in Type 1 Diabetes with stem cells.
Global Stem Cells Market to Generate Revenue of $25.68 Billion By 2028 | More than 80% of Revenue Comes from Adult Stem Cells
Westford,USA, Nov. 02, 2022 (GLOBE NEWSWIRE) — The demand for stem cells market is growing rapidly as the potential for their use in medical treatments expands. In particular, there is great interest in using stem cells to treat a range of degenerative diseases and injuries, as well as to improve the success of organ transplants. Recent advances […]
Creative Medical Technology Holdings Develops AlloStem™ Clinical Cell Line
PHOENIX, Oct. 20, 2022 /PRNewswire/ — Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ), a biotechnology company focused on a regenerative approach to immunotherapy, endocrinology, urology, neurology, and orthopedics, announced today that through predominantly internal and collaborative development, it has produced an allogenic Cell Line called AlloStem™, which includes a Master Cell Bank and a Drug Master File which shall […]
Kadimastem Receives Approval of Patent Registration for Its Cell Selection and Enrichment Technology Used to Develop Its IsletRx Treatment for Diabetes in a Third Territory
NESS ZIONA, Israel, Sept. 28, 2022 /PRNewswire/ — Kadimastem Ltd. (TASE: KDST), a clinical stage cell therapy company developing treatments for ALS and diabetes, has been granted its third patent approval for the company’s innovative cell selection and enrichment technology and its use in the production of IsletRx, the company’s treatment and potential cure for diabetes. […]